The findings showed that both JAK2 silencing and JAK inhibitor treatment effectively reduced SASP expression in senescent NPCs, underscoring the pivotal role of the JAK2/STAT3 signaling pathway in SASP regulation and highlighting its therapeutic potential in mitigating disc degeneration. The gene discussed is STAT3; the disease is intervertebral disk degenerative disorder.